Fennec Pharmaceuticals In... (FENC)
6.78
-0.24 (-3.42%)
At close: Mar 03, 2025, 3:59 PM
6.77
-0.15%
After-hours: Mar 03, 2025, 04:00 PM EST
Fennec Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 |
| Cash & Equivalents | 13.27M | 23.77M | 21.1M | 30.34M | 13.65M | 22.78M | 28.26M | 3.93M | 942K | 2.31M | 1.66M | 2.3M | 5.3M | 5.95M | 685K | 5.35M | 16.16M | 5.67M | 11.97M | 13.67M | 2.15M | 207.06K | 9.35M | 111.12K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.18M | 7.11M | n/a | 5.37M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 6K | 211K | 27K | n/a | 262K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 440K | n/a | 19.64M | 21.84M | n/a | n/a | n/a |
| Receivables | 8.81M | 1.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 69K | 139K | 185K | 103K | 144K | 270.42K | 22.27K | 138.43K | 138.59K | 29.87K |
| Inventory | 2.16M | 576K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K | 123K | 185K | 94K | 59K | 151.12K | 328.88K | 251.95K | 0.00 | n/a |
| Other Current Assets | 2.62M | 833K | 1.29M | 1.07M | 234K | 169K | 141K | 46K | 77K | 65K | 89K | 62K | 54K | 46K | 79K | 99K | 214K | 127K | 111K | 517.85K | 572.32K | 324.43K | 470.53K | 294.89K |
| Total Current Assets | 26.86M | 26.73M | 22.39M | 31.42M | 13.88M | 22.95M | 28.4M | 3.97M | 1.02M | 2.37M | 1.75M | 2.37M | 5.35M | 5.99M | 833K | 5.64M | 16.56M | 5.89M | 13.4M | 21.68M | 3.33M | 6.18M | 9.94M | 435.87K |
| Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 421K | 648K | 293K | 892K | 420.33K | 486.27K | 632.91K | 519.99K | 207.32K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.96M | 14.15M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 6K | 211K | 27K | n/a | 262K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 421K | 648K | 10.69M | 15.05M | 20.06M | 22.33M | 632.91K | 519.99K | 207.32K |
| Total Assets | 26.86M | 26.94M | 22.41M | 31.42M | 14.15M | 22.95M | 28.4M | 3.97M | 1.02M | 2.37M | 1.75M | 2.37M | 5.35M | 5.99M | 833K | 6.06M | 17.21M | 16.58M | 28.45M | 41.73M | 25.66M | 6.82M | 10.46M | 643.19K |
| Account Payables | 3.78M | 2.39M | 777K | 1.57M | 1.61M | 1.03M | 855K | 244K | 297K | 308K | 212K | 259K | 342K | 272K | 318K | 547K | 532K | 2.07M | 1.39M | 1.48M | 1.48M | 1.04M | 635.52K | 441.27K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a |
| Short-Term Debt | 21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.64K | 24.64K |
| Other Current Liabilities | 3.75M | 2.22M | 877K | 776K | 659K | 605K | 789K | 158K | 174K | 1.45M | 3M | 7.06M | 5.13M | 10.64M | 102K | 1.88M | 1.87M | -1.02M | -3.9M | -8.89M | -483 | 47.51K | -134.9K | 59.34K |
| Total Current Liabilities | 7.55M | 4.61M | 1.65M | 2.35M | 2.27M | 1.64M | 1.64M | 402K | 471K | 1.76M | 3.21M | 7.32M | 5.47M | 10.92M | 420K | 2.43M | 2.4M | 4.7M | 2.66M | 1.48M | 1.09M | 694.09K | 525.25K | 479.51K |
| Long-Term Debt | 30.93M | 24.9M | 4.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.38K |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7K | 577K | 659K | 665K | 550K | 92.07K | 1.32M | 41.95K | 110.15K | 76.77K |
| Total Long-Term Liabilities | 30.93M | 24.9M | 4.99M | n/a | n/a | 1.03M | 855K | 244K | 297K | 308K | 212K | 259K | 342K | 272K | 7K | 577K | 659K | 4.3M | 5.72M | 7.26M | 9.26M | 41.95K | 110.15K | 116.95K |
| Total Liabilities | 38.49M | 29.51M | 6.64M | 2.35M | 2.27M | 1.64M | 1.64M | 402K | 471K | 1.76M | 3.21M | 7.32M | 5.47M | 10.92M | 427K | 3.01M | 3.06M | 9M | 8.39M | 8.73M | 10.35M | 736.04K | 635.41K | 596.46K |
| Total Debt | 30.95M | 24.9M | 4.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.41K | 59K |
| Common Stock | 144.31M | 142.59M | 140.8M | 140.73M | 106.39M | 106.39M | 103.05M | 74.52M | 69.15M | 68.66M | 66.79M | 65.95M | 65.95M | 64.93M | 64.93M | 64.93M | 64.93M | 46.49M | 41.27M | 48.34M | n/a | n/a | n/a | n/a |
| Retained Earnings | -219.25M | -203.2M | -179.49M | -162.14M | -144.03M | -131.26M | -121.37M | -114.32M | -111.53M | -110.87M | -108.7M | -110.54M | -105.38M | -108.81M | -100.99M | -97.98M | -84.38M | -71.5M | -52.4M | -25.49M | -16.58M | -9.1M | -5.4M | -3.01M |
| Comprehensive Income | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 5.85M | 5.85M | 22.23M | 12.93M | n/a | n/a | n/a |
| Shareholders Equity | -11.62M | -2.57M | 15.77M | 29.07M | 11.88M | 21.31M | 26.76M | 3.57M | 548K | 613K | -1.46M | -4.96M | -120K | -4.92M | 406K | 3.05M | 14.15M | 7.58M | 20.06M | 33M | 15.31M | 6.08M | 9.82M | 46.73K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.18M | 7.11M | n/a | 5.37M | n/a | n/a |